|
|
 |
|
Viewing report
|
|
|
|
Key Companies: Osteoporosis - Growing competition threatens leading franchises and drives innovation
Datamonitor, Nov 2011, Pages: 34
The osteoporosis market is dominated by large pharmaceutical companies that can leverage their considerable financial reserves to conduct large-scale clinical trials, and which have the marketing strength needed to penetrate this sector. Osteoporosis companies market one or two drugs for which they promote safety and patient convenience, and pursue indication expansions.
Features and benefits
- In-depth discussion of brand lifecycle and portfolio management strategies of key companies involved in the osteoporosis market.
- Review Merck & Co.'s and Servier’s osteoporosis portfolio management strategies and what challenges these companies are facing.
- Assess trends in corporate strategies of companies active in the osteoporosis arena and understand the impact of key recent licensing deals.
- Identify the leading companies involved in osteoporosis and how their franchises have been performing over 2005–10.
- Learn how companies can respond to future opportunities and challenges in the field.
Highlights
- Developing new technologies to improve compliance remains a popular portfolio management strategy in the osteoporosis market and the latest opportunity is for more conveniently dosed and administered anabolic drugs.
- Merck lost its market leading position due to generic erosion. With two novel therapies in development, the company now has an opportunity to restore its market share. However, the main challenge is to bring these drugs to market while maintaining relationships with key osteoporosis stakeholders.
- Servier has so far maintained a successful standing in Europe by promoting Protelos (strontium ranelate) as a novel effective and safe alternative therapy to bisphosphonates. However, in spite of the possible launch of a follow-on product, long term growth prospects will be hindered by future competition from generic strontium ranelate.
Your key questions answered
- Which are the leading companies in the osteoporosis market?
- How successful are the portfolio management strategies most widely used in the osteoporosis market?
- How is Merck & Co. attempting to regain its leading position?
- What makes Servier's osteoporosis offering unique?
- What are the main challenges companies are facing in this therapy area?
|
|
|
|
